{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T01:48:41Z","timestamp":1779241721835,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.bcp.2008.03.009","type":"journal-article","created":{"date-parts":[[2008,3,27]],"date-time":"2008-03-27T20:22:15Z","timestamp":1206649335000},"page":"2183-2191","source":"Crossref","is-referenced-by-count":14,"title":["Geldanamycin inhibits tyrosine phosphorylation-dependent NF-\u03baB activation"],"prefix":"10.1016","volume":"75","author":[{"given":"Julie","family":"Cr\u00e8vecoeur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Paule","family":"Merville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Piette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey","family":"Gloire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2008.03.009_bib1","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.it.2004.03.008","article-title":"The two NF-kappaB activation pathways and their role in innate and adaptive immunity","volume":"25","author":"Bonizzi","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.bcp.2008.03.009_bib2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","article-title":"Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity","volume":"18","author":"Karin","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.bcp.2008.03.009_bib3","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1101\/gad.1228704","article-title":"Signaling to NF-kappaB","volume":"18","author":"Hayden","year":"2004","journal-title":"Genes Dev"},{"issue":"Suppl.","key":"10.1016\/j.bcp.2008.03.009_bib4","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0092-8674(02)00703-1","article-title":"Missing pieces in the NF-kappaB puzzle","volume":"109","author":"Ghosh","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2008.03.009_bib5","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.bcp.2006.04.011","article-title":"NF-kappaB activation by reactive oxygen species: fifteen years later","volume":"72","author":"Gloire","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2008.03.009_bib6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0092-8674(00)80153-1","article-title":"Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha","volume":"86","author":"Imbert","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2008.03.009_bib7","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1074\/jbc.M206718200","article-title":"Tyrosine phosphorylation of I kappa B alpha activates NF kappa B through a redox-regulated and c-Src-dependent mechanism following hypoxia\/reoxygenation","volume":"278","author":"Fan","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2008.03.009_bib8","doi-asserted-by":"crossref","first-page":"7368","DOI":"10.1158\/0008-5472.CAN-07-0515","article-title":"Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death","volume":"67","author":"Lluis","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2008.03.009_bib9","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1046\/j.1432-1327.2001.02028.x","article-title":"Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases","volume":"268","author":"Livolsi","year":"2001","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bcp.2008.03.009_bib10","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1038\/sj.onc.1210544","article-title":"Epidermal growth factor (EGF) activates nuclear factor-kappaB through IkappaBalpha kinase-independent but EGF receptor-kinase dependent tyrosine 42 phosphorylation of IkappaBalpha","volume":"26","author":"Sethi","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2008.03.009_bib11","doi-asserted-by":"crossref","first-page":"9664","DOI":"10.1523\/JNEUROSCI.0608-07.2007","article-title":"Nuclear factor-kappaB activation via tyrosine phosphorylation of inhibitor kappaB-alpha is crucial for ciliary neurotrophic factor-promoted neurite growth from developing neurons","volume":"27","author":"Gallagher","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2008.03.009_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0163-7258(98)00013-8","article-title":"The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review","volume":"79","author":"Csermely","year":"1998","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bcp.2008.03.009_bib13","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s00109-004-0549-9","article-title":"Targeting multiple signal transduction pathways through inhibition of Hsp90","volume":"82","author":"Zhang","year":"2004","journal-title":"J Mol Med"},{"key":"10.1016\/j.bcp.2008.03.009_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1042\/BJ20071640","article-title":"The Hsp90 molecular chaperone: an open and shut case for treatment","volume":"410","author":"Pearl","year":"2008","journal-title":"Biochem J"},{"key":"10.1016\/j.bcp.2008.03.009_bib15","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2174\/1381612053507585","article-title":"Hsp90 inhibitor geldanamycin and its derivatives as novel cancer chemotherapeutic agents","volume":"11","author":"Miyata","year":"2005","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bcp.2008.03.009_bib16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2217\/14796694.1.4.529","article-title":"HSP90: a rising star on the horizon of anticancer targets","volume":"1","author":"Dai","year":"2005","journal-title":"Future Oncol"},{"key":"10.1016\/j.bcp.2008.03.009_bib17","doi-asserted-by":"crossref","first-page":"8324","DOI":"10.1073\/pnas.91.18.8324","article-title":"Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation","volume":"91","author":"Whitesell","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2008.03.009_bib18","doi-asserted-by":"crossref","first-page":"442","DOI":"10.7164\/antibiotics.23.442","article-title":"Geldanamycin, a new antibiotic","volume":"23","author":"DeBoer","year":"1970","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.bcp.2008.03.009_bib19","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1128\/MCB.6.6.2198","article-title":"Phenotypic change from transformed to normal induced by benzoquinonoid ansamycins accompanies inactivation of p60src in rat kidney cells infected with Rous sarcoma virus","volume":"6","author":"Uehara","year":"1986","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2008.03.009_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF00689048","article-title":"Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent","volume":"36","author":"Supko","year":"1995","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bcp.2008.03.009_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2174\/1568009033481831","article-title":"Clinical development of 17-allylamino, 17-demethoxygeldanamycin","volume":"3","author":"Sausville","year":"2003","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.bcp.2008.03.009_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002800050817","article-title":"The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin","volume":"42","author":"Schulte","year":"1998","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bcp.2008.03.009_bib23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00280-004-0947-2","article-title":"Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models","volume":"56","author":"Smith","year":"2005","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bcp.2008.03.009_bib24","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1083\/jcb.143.4.901","article-title":"In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis","volume":"143","author":"Obermann","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bcp.2008.03.009_bib25","doi-asserted-by":"crossref","first-page":"17525","DOI":"10.1074\/jbc.274.25.17525","article-title":"The importance of ATP binding and hydrolysis by hsp90 in formation and function of protein heterocomplexes","volume":"274","author":"Grenert","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2008.03.009_bib26","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S1097-2765(03)00065-0","article-title":"Structural and functional analysis of the middle segment of hsp90: implications for ATP hydrolysis and client protein and cochaperone interactions","volume":"11","author":"Meyer","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.bcp.2008.03.009_bib27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0092-8674(00)80314-1","article-title":"Identification and structural characterization of the ATP\/ADP-binding site in the Hsp90 molecular chaperone","volume":"90","author":"Prodromou","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2008.03.009_bib28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1097-2765(02)00450-1","article-title":"TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90","volume":"9","author":"Chen","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.bcp.2008.03.009_bib29","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.1038\/sj.onc.1207705","article-title":"Requirement of Hsp90 activity for IkappaB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-kappaB activation","volume":"23","author":"Broemer","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2008.03.009_bib30","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/sj.cr.7310109","article-title":"Hsp90 inhibition results in autophagy-mediated proteasome-independent degradation of IkappaB kinase (IKK)","volume":"16","author":"Qing","year":"2006","journal-title":"Cell Res"},{"key":"10.1016\/j.bcp.2008.03.009_bib31","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4049\/jimmunol.174.1.384","article-title":"Stress-induced inhibition of the NF-kappaB signaling pathway results from the insolubilization of the IkappaB kinase complex following its dissociation from heat shock protein 90","volume":"174","author":"Pittet","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2008.03.009_bib32","doi-asserted-by":"crossref","first-page":"32311","DOI":"10.1074\/jbc.M705785200","article-title":"Signal responsiveness of IkappaB kinases is determined by Cdc37-assisted transient interaction with Hsp90","volume":"282","author":"Hinz","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2008.03.009_bib33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/jcp.1131","article-title":"Hsp90: chaperoning signal transduction","volume":"188","author":"Richter","year":"2001","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.bcp.2008.03.009_bib34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1073\/pnas.96.1.109","article-title":"Maturation of the tyrosine kinase c-src as a kinase and as a substrate depends on the molecular chaperone Hsp90","volume":"96","author":"Xu","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2008.03.009_bib35","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1091\/mbc.11.5.1585","article-title":"Hsp90 is essential for the synthesis and subsequent membrane association, but not the maintenance, of the Src-kinase p56(lck)","volume":"11","author":"Bijlmakers","year":"2000","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.bcp.2008.03.009_bib36","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/S0021-9258(19)50671-8","article-title":"Reconstitution of the multiprotein complex of pp60src, hsp90, and p50 in a cell-free system","volume":"267","author":"Hutchison","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2008.03.009_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-5793(01)02130-5","article-title":"Opposite effects of the Hsp90 inhibitor Geldanamycin: induction of apoptosis in PC12, and differentiation in N2A cells","volume":"490","author":"Lopez-Maderuelo","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2008.03.009_bib38","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.yexcr.2005.03.003","article-title":"Differential effects of Hsp90 inhibition on protein kinases regulating signal transduction pathways required for myoblast differentiation","volume":"307","author":"Yun","year":"2005","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.bcp.2008.03.009_bib39","first-page":"355","article-title":"The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-abl and v-src proteins before their degradation by the proteasome","volume":"11","author":"An","year":"2000","journal-title":"Cell Growth Differ"},{"key":"10.1016\/j.bcp.2008.03.009_bib40","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.4049\/jimmunol.164.8.4292","article-title":"Crucial role of the amino-terminal tyrosine residue 42 and the carboxyl-terminal PEST domain of I kappa B alpha in NF-kappa B activation by an oxidative stress","volume":"164","author":"Schoonbroodt","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2008.03.009_bib41","doi-asserted-by":"crossref","first-page":"10519","DOI":"10.1074\/jbc.275.14.10519","article-title":"Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation","volume":"275","author":"Lewis","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2008.03.009_bib42","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1046\/j.1432-1327.1999.00587.x","article-title":"Inhibition of tyrosine phosphatases antagonizes CD95-mediated apoptosis","volume":"264","author":"Hehner","year":"1999","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bcp.2008.03.009_bib43","doi-asserted-by":"crossref","first-page":"7074","DOI":"10.1073\/pnas.90.15.7074","article-title":"Heat-shock protein hsp90 governs the activity of pp60v-src kinase","volume":"90","author":"Xu","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2008.03.009_bib44","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1128\/MCB.24.13.5667-5676.2004","article-title":"Regulation of the Src family kinase Lck by Hsp90 and ubiquitination","volume":"24","author":"Giannini","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2008.03.009_bib45","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1124\/mol.106.024240","article-title":"Geldanamycin interferes with the 90-kDa heat shock protein, affecting lipopolysaccharide-mediated interleukin-1 expression and apoptosis within macrophages","volume":"71","author":"Hsu","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2008.03.009_bib46","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/cr.2007.47","article-title":"Hsp90 regulates processing of NF-kappaB2 p100 involving protection of NF-kappaB-inducing kinase (NIK) from autophagy-mediated degradation","volume":"17","author":"Qing","year":"2007","journal-title":"Cell Res"},{"key":"10.1016\/j.bcp.2008.03.009_bib47","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1126\/science.1098387","article-title":"Activation of transcription factor NF-kappaB requires ELKS, an IkappaB kinase regulatory subunit","volume":"304","author":"Ducut Sigala","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bcp.2008.03.009_bib48","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.4049\/jimmunol.164.6.2915","article-title":"Effects of geldanamycin, a heat-shock protein 90-binding agent, on T cell function and T cell nonreceptor protein tyrosine kinases","volume":"164","author":"Yorgin","year":"2000","journal-title":"J Immunol"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295208001895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295208001895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T17:20:02Z","timestamp":1630948802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295208001895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0006295208001895"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2008.03.009","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}